SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-24-013046
Filing Date
2024-02-13
Accepted
2024-02-13 13:20:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea193576-13ga2gordon_neuro.htm SC 13G/A 37946
  Complete submission text file 0001213900-24-013046.txt   39277
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Subject) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93172 | Film No.: 24624273
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14 RAUL WALLENBERG RAANANA L3 4320846
Business Address
Gordon Ariel (Filed by) CIK: 0001899930 (see all company filings)

Type: SC 13G/A